Jeffrey Stein

President & CEO

Jeffrey Stein (President & CEO) filed 2 Form 4 reports in the trailing twelve months (2 purchases, 0 sales, 1 filed past the two-business-day deadline), most often in CDTX. Across 1 priced purchase filing, the average 21-session return was -1.1% from execution and -1.1% from disclosure (delay-adjusted; derived). The largest single filing was $1.6M of IDYA (50,000 sh × $32.96, as filed), executed Mar 2.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

-1.1%

avg across 1 priced filings

Delay-adjustediThe same average, entered at disclosure dates

-1.1%

same 1 filings, from disclosure

Filings, ttm

2 buys · 0 sells · 1 late

Median delay

942d

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$1.7M

shares × price, as filed

Last traded

Mar 2

Filed Mar 2

Median ADV $41.2M across their filed names

50% of their measured filings could not be priced (delisted or unquoted names). The returns above cover only what still trades.

Open performance→

Volume by month

Buys $1.7M Sells $0

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names

CDTX CDTX CDTX · 1 buy · 0 sells 1 filing IDYA

IDEAYA Biosciences, Inc. IDYA · 1 buy · 0 sells 1 filing

Recent filings

IDYAPURCHASE IDEAYA Biosciences, Inc. View filing → $1.6M
50,000 sh × $32.96
Exec Mar 2
Filed Mar 2 · 7:18 PM ET CDTXPURCHASE Cidara Therapeutics, Inc. View filing → $100K
2,500 sh × $40.01
Exec Nov 10 2020
Filed Jan 7 · 8:12 PM ET †